These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 8587452)

  • 1. Does endothelin play a role in the pathogenesis of early diabetic nephropathy?
    Lam HC; Lee JK; Chiang HT; Koh SJ; Han TM; Lu CC; Yang CY; Hao LJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S479-81. PubMed ID: 8587452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes.
    Zerbini G; Bonfanti R; Meschi F; Bognetti E; Paesano PL; Gianolli L; Querques M; Maestroni A; Calori G; Del Maschio A; Fazio F; Luzi L; Chiumello G
    Diabetes; 2006 Sep; 55(9):2620-5. PubMed ID: 16936212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renal hemodynamic basis of diabetic nephropathy.
    O'Bryan GT; Hostetter TH
    Semin Nephrol; 1997 Mar; 17(2):93-100. PubMed ID: 9148381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between elevated plasma endothelin-1 level and renal function in patients with diabetic nephropathy].
    Wang L; Yu Z; Mao T
    Zhonghua Nei Ke Za Zhi; 1995 May; 34(5):318-21. PubMed ID: 8565716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition.
    Vora JP; Leese GP; Peters JR; Owens DR
    J Diabetes Complications; 1996; 10(2):88-93. PubMed ID: 8777336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of natriuresis in diabetic nephropathy].
    Późniak J
    Ann Acad Med Stetin; 2000; 46():241-52. PubMed ID: 11712308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
    Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
    Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New and old markers of progression of diabetic nephropathy.
    Jerums G; Premaratne E; Panagiotopoulos S; Clarke S; Power DA; MacIsaac RJ
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S30-7. PubMed ID: 18937992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S; Blohmé G; Sylvén C; Mulec H
    Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy.
    Toyoda M; Najafian B; Kim Y; Caramori ML; Mauer M
    Diabetes; 2007 Aug; 56(8):2155-60. PubMed ID: 17536064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
    Navarro JF; Mora C; Muros M; García J
    Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
    Popławska-Kita A; Mierzejewska-Iwanowska B; Szelachowska M; Siewko K; Nikołajuk A; Kinalska I; Górska M
    Diabetes Metab Res Rev; 2008; 24(4):310-7. PubMed ID: 18273859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin in diabetic renal disease.
    Benz K; Amann K
    Contrib Nephrol; 2011; 172():139-148. PubMed ID: 21893995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes mellitus and its complications in Japan. The dysfunction of mesangial cells on pathogenesis of diabetic nephropathy].
    Shigeta Y; Kikkawa R
    Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1442-5. PubMed ID: 1761925
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased urinary endothelin-1 excretion in newly diagnosed type 2 diabetic patients.
    Shin SJ; Hsiao PJ; Hsieh MC; Lee YJ; Tsai JH
    Kaohsiung J Med Sci; 1999 Oct; 15(10):589-96. PubMed ID: 10603706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endothelin system function in diabetic nephropathy].
    Zanatta CM; Canani LH; Silveiro SP; Burttet L; Nabinger G; Gross JL
    Arq Bras Endocrinol Metabol; 2008 Jun; 52(4):581-8. PubMed ID: 18604370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Symposium on renal involvement in systemic diseases. I. Diabetes mellitus. (1) Diabetic nephropathy. Intrarenal microaneurysms (author's transl)].
    Nakamoto Y; Takazakura E
    Nihon Naika Gakkai Zasshi; 1979 Oct; 68(10):1228-33. PubMed ID: 533794
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical significance of urinary acid-soluble protein in diabetic nephropathy].
    Kanauchi M; Sawai F; Hirayama T; Yumura F; Hamaguchi T; Nishiura K; Dohi K; Ishikawa H
    Nihon Jinzo Gakkai Shi; 1986 Oct; 28(10):1329-36. PubMed ID: 3820809
    [No Abstract]   [Full Text] [Related]  

  • 20. Endothelin, nitric oxide, and reactive oxygen species in diabetic kidney disease.
    Pollock JS; Pollock DM
    Contrib Nephrol; 2011; 172():149-159. PubMed ID: 21893996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.